Table 6 Baseline characteristics of the entire cohort. Total PSA (tPSA), free/total PSA (ftPSA)
Clinical variables | PCA (n = 79) | BPH (n = 84) | p-value |
|---|---|---|---|
Age (years), median (IQR) | 69 (64.5–73.5) | 69 (62–72.5) | 0.13 |
Prostate dimension (cc), median (IQR) | 40 (30–50) | 55 (40–78) |  < 0.05 |
ProPSA, median (IQR) | 553.9 (385.7–996) | 257.7 (87–440) |  < 0.05 |
tPSA, median (IQR) | 8.05 (5.66–15.85) | 2.4 (0.93–4.84) | 0.09 |
ftPSA, median (IQR) | 16 (12–22) | 35 (24–45) |  < 0.05 |
fPSA, median (IQR) | 1.43 (0.99–2.7) | 0.81 (0.28–1.72) | 0.23 |
Gleason 6, n (%) | 26 (33%) | N/A | Â |
Gleason 7 (3 + 4), n (%) | 22 (28%) | N/A |  |
Gleason 7 (4 + 3), n (%) | 16 (20) | N/A |  |
Gleason ≥ 8, n (%) | 15 (19) | N/A |  |